DAY 1 · SCIENTIFIC INTEGRITY P2

iCIDM Claim Register v1.0

Public numbers and state-bearing statements are now auditable candidate objects.

338
Candidate claims
267
Quantitative
71
State / boundary
Boundary: extraction creates a review queue, not validated claims. Evidence binding and HI review remain pending.

Claim → Evidence → Boundary → Review Status → Page

IDPageClaimTypeStatus
ICIDM-CLAIM-0001icidm_colleague_beta.htmlbody{margin:0;background:#ebe7df;color:#172825;font-family:system-ui,-apple-system,"PingFang SC";line-height:1.55}main{max-width:1050px;margin:auto;padding:22px}section{background:#fffdf8;border:1px solid #d7d0c4;border-radius:20px;padding:22px;margin:10px 0}.hero{background:linear-gradient(135deg,#dff1ea,#fff0df,#eee7f4)}.k{font-size:11px;letter-spacing:.12em;color:#27665c;font-weight:850}h1{font-size:44px;line-h...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0002icidm_colleague_beta.html31 years of CIDM — explore it as a living scientific institutionQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0003icidm_colleague_beta.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0004icidm_colleague_beta.htmlWhat did CIDM publish? Start from the 2,231-paper institutional memory.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0005icidm_colleague_beta.htmlHow did a capability emerge? Follow reviewed roads through time, methods and research domains.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0006icidm_colleague_beta.htmlWhat might we have missed? Inspect candidate gaps. They are questions, not conclusions.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0007icidm_colleague_beta.htmlCan iCIDM learn from a mistake? See how a candidate judgement is reviewed, corrected and preserved as a lesson.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0008icidm_colleague_beta.html2,231 Publication Explorer · RECOVERED Search title, authors, PMID, DOI, year, theme, pathogen and technology.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0009icidm_colleague_beta.htmlCIDM Navigator · RECOVERED 3,299 source-derived typed routes with explicit evidence boundaries.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0010icidm_colleague_beta.htmlDigital CIDM · RECOVERED 2,231 publication objects and 8,061 source-derived typed links.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0011icidm_colleague_beta.html460 Reference Gateway · RECOVERED ARCHITECTURE Reference architecture restored; canonical reference population remains a controlled recovery boundary.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0012icidm_colleague_beta.htmlThe 31-year corpus can now be explored at several scalesQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0013icidm_colleague_beta.html178 Knowledge Journeys Repeated pathogen×technology and theme×technology roads across time; observational, not automatically validated.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0014icidm_colleague_beta.html20 Signature Journey Candidates Prominent corpus pathways selected by transparent structural criteria; selection is not validation.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0015icidm_colleague_beta.htmlEvidence Chains Move from a claim to candidate supporting papers, review and eventual evidence navigation.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0016icidm_colleague_beta.html21 colleague-facing pages were checked. Current internal-link audit found 13 remaining broken-link occurrences within this beta-facing set.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0017icidm_colleague_beta.htmlP1 has started: key pages now carry a common boundary explaining that observed ≠ candidate ≠ reviewed ≠ validated .STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0018icidm_colleague_beta.htmlBefore colleagues interpret a graph, journey, gap or future direction, the site distinguishes corpus observation from candidate interpretation, human review, validation and proposal.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0019icidm.htmliCIDM · iSydney body{margin:0;font-family:Inter,system-ui;background:#eeeae2;color:#172825;line-height:1.5}.wrap{max-width:1150px;margin:auto;padding:28px}.hero,.card{background:#fffdf8;border:1px solid #d7d0c4;border-radius:20px;padding:22px}.hero{background:linear-gradient(135deg,#e5f3ed,#fff0df);padding:38px}h1{font-size:54px;margin:4px 0}.k{font-size:12px;letter-spacing:.15em;text-transform:uppercase;font-weig...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0020icidm.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0021icidm.htmlNEW · Observer-aware RI-001QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0022icidm.htmlUse a transparent candidate queue to move from evidence gaps, old assets, signature journeys and unresolved questions toward reviewable Reality Return actions.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0023cidm.htmlCIDM Institution Passport · iSydney body{margin:0;font-family:Inter,system-ui;background:#ece8df;color:#172725;line-height:1.5}a{color:inherit;text-decoration:none}.top{position:sticky;top:0;background:#fffdf8ee;border-bottom:1px solid #d7d0c4;padding:14px 24px;display:flex;justify-content:space-between;z-index:3}.wrap{max-width:1200px;margin:auto;padding:24px}.hero{background:linear-gradient(135deg,#e8f3ee,#fff3e...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0024cidm.htmliSydney Founding Reality District CIDM Citizens 26 Letters Explorer MuseumQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0025cidm.html2,231 curated publications (1995–2026 project corpus), ready to connect authors, pathogens, technologies, themes, questions and evidence.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0026cidm.html460 active reference passports , designed for provenance, status, reuse and relationship navigation.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0027cidm.htmlNext data step: import the actual 2,231-publication and 460-reference records into the City object graph rather than manufacturing placeholder paper records.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0028digital_cidm.htmlDigital CIDM · iSydney body{margin:0;font-family:Inter,system-ui;background:#ece8df;color:#172725;line-height:1.45}a{color:inherit;text-decoration:none}.top{position:sticky;top:0;z-index:5;background:#fffdf8f2;border-bottom:1px solid #d7d0c4;padding:13px 22px;display:flex;justify-content:space-between}.wrap{max-width:1280px;margin:auto;padding:22px}.hero{background:linear-gradient(135deg,#e8f3ee,#fff3e5);border:1p...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0029digital_cidm.htmliSydney Digital CIDM 2,231 Explorer Knowledge District CIDM Passport Citizens MuseumQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0030digital_cidm.htmlThe CIDM publication corpus is now represented as 2,231 real publication objects with stable City IDs and source-derived links to themes, pathogens, technologies, journals and investigator-search sources. This is no longer a mock population.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0031digital_cidm.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0032digital_cidm.html2,231 real publication objectsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0033digital_cidm.html8,061 source-derived typed linksQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0034digital_cidm.html504 journal objectsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0035digital_cidm.html99 theme objectsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0036digital_cidm.html23 specified pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0037digital_cidm.htmlBrowse all 2,231 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0038digital_cidm.htmlEach retained 1995–2026 publication receives a stable Digital CIDM ID from CPD-0001 to CPD-2231.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0039digital_cidm.htmlClinical microbiology / infectious diseases — 657 COVID-19 / respiratory viruses — 194 Diagnostics / laboratory methods — 136 Clinical infectious diseases — 128 Medical mycology — 112QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0040digital_cidm.htmlInfluenza / respiratory viruses — 119 SARS-CoV-2 — 113 Cryptococcus — 97 Candida / Candidozyma — 81 Staphylococcus aureus / MRSA — 54QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0041digital_cidm.htmlCulture / phenotypic methods — 451 Clinical trial / therapy — 146 Whole-genome sequencing; Culture / phenotypic methods — 120 Serology / immunology — 86 PCR / molecular diagnostics — 72QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0042digital_cidm.htmlDigital CIDM is a reality-linked reference implementation. The 2,231 records are source-derived; institutional affiliation verification remains an explicit curation boundary.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0043cidm_publication_explorer.htmlPublication Explorer · iSydney body{margin:0;font-family:Inter,system-ui;background:#ece8df;color:#172725;line-height:1.45}a{color:inherit;text-decoration:none}.top{position:sticky;top:0;z-index:5;background:#fffdf8f2;border-bottom:1px solid #d7d0c4;padding:13px 22px;display:flex;justify-content:space-between}.wrap{max-width:1280px;margin:auto;padding:22px}.hero{background:linear-gradient(135deg,#e8f3ee,#fff3e5);b...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0044cidm_publication_explorer.htmliSydney Digital CIDM 2,231 Explorer Knowledge District CIDM Passport Citizens MuseumQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0045cidm_publication_explorer.html2,231 real publication citizensQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0046cidm_publication_explorer.htmlSearch the canonical 1995–2026 slice of the CIDM PubMed master. Click any publication to inspect its City Passport and source-derived connections.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0047cidm_publication_explorer.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0048cidm_publication_explorer.htmlAll years 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 All themes Clinical microbiology / infectious diseases COVID-19 / respiratory viruses Diagnostics / laboratory methods Clinical infectious diseases Medical mycology Antimicrobial resistance Public health / epidemiology Genomics / bioinformatics Me...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0049cidm_publication_explorer.html2,231 publications shown. Classification fields are source-derived from the workbook; affiliation verification remains pending.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0050cidm_publication_explorer.htmlDigital CIDM is a reality-linked reference implementation. The 2,231 records are source-derived; institutional affiliation verification remains an explicit curation boundary.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0051cidm_navigator.htmlCIDM Navigator · iSydney body{margin:0;font-family:Inter,system-ui;background:#ece8df;color:#172725;line-height:1.45}a{color:inherit;text-decoration:none}.top{position:sticky;top:0;z-index:5;background:#fffdf8f2;border-bottom:1px solid #d7d0c4;padding:13px 22px;display:flex;justify-content:space-between}.wrap{max-width:1280px;margin:auto;padding:22px}.hero{background:linear-gradient(135deg,#e8f3ee,#fff3e5);border:...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0052cidm_navigator.htmliSydney Digital CIDM 2,231 Explorer CIDM Navigator 460 Reference Gateway MuseumQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0053cidm_navigator.htmlThe 2,231 publication citizens are no longer only searchable. They now have deterministic, typed routes derived from the master workbook's bibliographic and CKID classification fields.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0054cidm_navigator.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0055cidm_navigator.html3,299 typed Navigator routesQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0056cidm_navigator.html1,135 publication → theme → technologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0057cidm_navigator.html439 publication → pathogen → technologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0058cidm_navigator.html959 publications with ≥2 routesQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0059cidm_navigator.htmlWhen the canonical 460-reference population is recovered, add Paper → Active Reference → Evidence / Question routes without changing this architecture.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0060cidm_navigator.htmlUse Explorer to generate candidate future questions, then require explicit review before Navigator makes them trusted journeys.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0061cidm_knowledge_journeys.htmlCIDM Knowledge Journeys · iSydney body{margin:0;background:#eeeae2;color:#172825;font-family:Inter,system-ui;line-height:1.5}.wrap{max-width:1250px;margin:auto;padding:24px}.hero,.card,.journey{background:#fffdf8;border:1px solid #d7d0c4;border-radius:18px;padding:18px}.hero{padding:32px;background:linear-gradient(135deg,#e6f2ed,#fff0df)}h1{font-size:42px;line-height:1.05;margin:7px 0}.k{font-size:11px;text-transf...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0062cidm_knowledge_journeys.htmliSydney Digital CIDM Explorer Navigator Knowledge Journeys 460 GatewayQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0063cidm_knowledge_journeys.htmlInstead of stopping at individual papers, Digital CIDM now detects repeated roads through the 31-year corpus. A journey is an observed cohort such as Pathogen → Technology → Publications across time or Theme → Technology → Publications across time .QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0064cidm_knowledge_journeys.htmlImportant: these are corpus-derived observational pathways. They are deliberately not labelled “validated capabilities” or “new research questions” yet. Those promotions require evidence/passport review.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0065cidm_knowledge_journeys.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0066cidm_knowledge_journeys.html178 observed knowledge journeysQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0067cidm_knowledge_journeys.html58 pathogen × technology journeysQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0068cidm_knowledge_journeys.html120 theme × technology journeysQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0069cidm_knowledge_journeys.html13 technology capability candidatesQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0070cidm_knowledge_journeys.htmlRepeated relationship visible in the 2,231-paper population.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0071cidm_knowledge_journeys.htmlRepresentative papers and references reviewed through passports.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0072cidm_signature_journeys.htmlCIDM Signature Journeys · iSydney body{margin:0;background:#eeeae2;color:#172825;font-family:Inter,system-ui;line-height:1.5}.wrap{max-width:1260px;margin:auto;padding:24px}.hero,.card,.sj{background:#fffdf8;border:1px solid #d7d0c4;border-radius:18px;padding:18px}.hero{padding:32px;background:linear-gradient(135deg,#e6f2ed,#fff0df)}h1{font-size:42px;line-height:1.05;margin:7px 0}.k{font-size:11px;text-transform:u...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0073cidm_signature_journeys.htmliSydney Digital CIDM Explorer Navigator All Journeys Signature Journeys Capability Review 460 GatewayQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0074cidm_signature_journeys.html20 Signature Journey CandidatesQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0075cidm_signature_journeys.htmlThese are the strongest corpus-level pathways selected from the 178 observed journeys using only transparent structural criteria: publication volume, temporal span, journal diversity and recent activity.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0076cidm_signature_journeys.htmlSelection ≠ validation. A high signature score only says a pathway is prominent in the current corpus. It does not prove scientific importance, institutional ownership, or capability until representative evidence is reviewed.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0077cidm_signature_journeys.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0078cidm_signature_journeys.html20 signature candidatesQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0079cidm_signature_journeys.html648 paper appearances across top 20QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0080cidm_signature_journeys.html32 maximum temporal span (years)QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0081cidm_signature_journeys.htmlCIDMKJ-0001 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0082cidm_signature_journeys.html110 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0083cidm_signature_journeys.htmlcandidate · evidence reviewSTATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0084cidm_signature_journeys.html1997 · Helicobacter westmeadii sp. nov., a new species isolated from blood cultures of two AIDS patients. 1999 · Australian isolates of Legionella longbeachae are not a clonal population. 2001 · Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. 2001 · Human breathing and eye blink rate responses to airborne chemicals.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0085cidm_signature_journeys.htmlCIDMKJ-0004 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0086cidm_signature_journeys.html40 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0087cidm_signature_journeys.html1997 · Formulary management in a military treatment facility. 1997 · Advances in antiviral therapy. 1999 · AIDS dementia complex: response to highly active antiretroviral therapy. 2001 · Changes in HIV-1 viral load trends with highly active antiretroviral therapy.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0088cidm_signature_journeys.htmlCIDMKJ-0002 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0089cidm_signature_journeys.htmlCOVID-19 / respiratory virusesQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0090cidm_signature_journeys.html56 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0091cidm_signature_journeys.html1999 · Barmah Forest virus epidemic on the south coast of New South Wales, Australia, 1994-1995: viruses, vectors, human cases, and environmental factors. 1999 · Pulsed-field gel electrophoresis used to investigate genetic diversity of Haemophilus influenzae type b isolates in Australia shows differences between Aboriginal and non-Aboriginal isolates. 2000 · Arboviruses associated with human disease in Australia. ...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0092cidm_signature_journeys.htmlCIDMKJ-0003 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0093cidm_signature_journeys.html51 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0094cidm_signature_journeys.html2002 · Biochemical characterization of the kinase domain of the rice disease resistance receptor-like kinase XA21. 2005 · Wide dissemination of a carbapenemase plasmid among gram-negative bacteria: implications of the variable phenotype. 2006 · Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. 2007 · Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's ...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0095cidm_signature_journeys.htmlCIDMKJ-0005 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0096cidm_signature_journeys.html38 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0097cidm_signature_journeys.html1996 · Characterization of Cryptococcus neoformans by random DNA amplification. 1996 · Natural environmental sources of Cryptococcus neoformans var. gattii. 1997 · Ecology of Cryptococcus neoformans. 1999 · Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0098cidm_signature_journeys.htmlCIDMKJ-0006 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0099cidm_signature_journeys.html36 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0100cidm_signature_journeys.html2003 · Characterization of the natural population of Bartonella henselae by multilocus sequence typing. 2004 · Postgenomic taxonomy of human ureaplasmas -- a case study based on multiple gene sequences. 2005 · Functional genomics of protein kinases in plants. 2005 · Comparison of a 3-set genotyping system with multilocus sequence typing for Streptococcus agalactiae (Group B Streptococcus).QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0101cidm_signature_journeys.htmlCIDMKJ-0009 · Pathogen × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0102cidm_signature_journeys.html30 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0103cidm_signature_journeys.html1997 · Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. 2003 · Rapid identification of Candida species by using nuclear magnetic resonance spectroscopy and a statistical classification strategy. 2005 · A rapid screening test to distinguish between Candida albicans and Candida dubliniensis using NMR spectr...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0104cidm_signature_journeys.htmlCIDMKJ-0007 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0105cidm_signature_journeys.html33 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0106cidm_signature_journeys.html1996 · Comparison of cell culture, mouse inoculation, and PCR for detection of Toxoplasma gondii: effects of storage conditions on sensitivity. 1999 · Is it time to replace the Petri dish with PCR? Application of culture-independent nucleic acid amplification in diagnostic bacteriology: expectations and reality. 2000 · Rapid-cycle PCR for detection and typing of Mycoplasma pneumoniae in clinical specimens. 2000 · ...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0107cidm_signature_journeys.htmlCIDMKJ-0013 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0108cidm_signature_journeys.html24 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0109cidm_signature_journeys.html1999 · Significance of plasma and peripheral blood mononuclear cell derived HIV-1 sequences in establishing epidemiologic linkage between two individuals multiply exposed to HIV-1. 2009 · The changing nature of clinical decision support systems: a focus on consumers, genomics, public health and decision safety. 2015 · Defining the Core Genome of Salmonella enterica Serovar Typhimurium for Genomic Surveillance and ...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0110cidm_signature_journeys.htmlCIDMKJ-0010 · Pathogen × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0111cidm_signature_journeys.html1999 · Pulsed-field gel electrophoresis used to investigate genetic diversity of Haemophilus influenzae type b isolates in Australia shows differences between Aboriginal and non-Aboriginal isolates. 2004 · Avian influenza and planning for pandemics. 2006 · Challenges for the laboratory before and during an influenza pandemic. 2006 · Laboratory diagnosis of human seasonal and pandemic influenza virus infection.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0112cidm_signature_journeys.htmlCIDMKJ-0011 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0113cidm_signature_journeys.html25 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0114cidm_signature_journeys.html1995 · Reconstitution of Arabidopsis casein kinase II from recombinant subunits and phosphorylation of transcription factor GBF1. 1995 · Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. 1997 · Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. 1997 · Usual inters...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0115cidm_signature_journeys.htmlCIDMKJ-0014 · Pathogen × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0116cidm_signature_journeys.html23 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0117cidm_signature_journeys.html1996 · Characterization of Cryptococcus neoformans by random DNA amplification. 1996 · Natural environmental sources of Cryptococcus neoformans var. gattii. 1997 · Ecology of Cryptococcus neoformans. 1999 · Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0118cidm_signature_journeys.htmlCIDMKJ-0012 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0119cidm_signature_journeys.html1995 · A comparison of chemical dipsticks read visually or by photometry in the routine screening of urine specimens in the clinical microbiology laboratory. 1998 · Evaluation of four methods for rapid identification of Staphylococcus aureus from blood cultures. 1998 · Isolation of Serpulina pilosicoli from rectal biopsy specimens showing evidence of intestinal spirochetosis. 1999 · Comparative analysis and serova...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0120cidm_signature_journeys.htmlCIDMKJ-0008 · Pathogen × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0121cidm_signature_journeys.html31 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0122cidm_signature_journeys.html2020 · Rapid deployment of pathology services to a remote Australian quarantine setting during the COVID-19 pandemic. 2020 · Donor heart selection during the COVID-19 pandemic: A case study. 2020 · Changes in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment. 2020 · SARS-CoV-2 endgame: attitudes and predictions of Australian and New Zealand i...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0123cidm_signature_journeys.htmlCIDMKJ-0015 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0124cidm_signature_journeys.html21 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0125cidm_signature_journeys.html1996 · Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique. 1997 · Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. 1999 · Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence f...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0126cidm_signature_journeys.htmlCIDMKJ-0016 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0127cidm_signature_journeys.html20 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0128cidm_signature_journeys.html2000 · Sedation for vitreoretinal surgery: a comparison of anaesthetist-administered midazolam and patient-controlled sedation with propofol. 2001 · Human responses to propionic acid. II. Quantification of breathing responses and their relationship to perception. 2003 · Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons. 2003 · Human odor detectabilit...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0129cidm_signature_journeys.htmlCIDMKJ-0017 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0130cidm_signature_journeys.html16 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0131cidm_signature_journeys.html1996 · Subtype B isolates of human immunodeficiency virus type 1 detected in Australia. 1996 · Length polymorphism of the viral protein R of human immunodeficiency virus type 1 strains. 1996 · Differing antibody responses to Haemophilus influenzae type b after meningitis or epiglottitis. 1998 · Human immunodeficiency virus type 1 subtypes B and C detected in New Zealand.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0132cidm_signature_journeys.htmlCIDMKJ-0025 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0133cidm_signature_journeys.html12 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0134cidm_signature_journeys.html1996 · An HIV-1 infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes. 1998 · Molecular cloning and chromosomal mapping of type one serine/threonine protein phosphatases in Arabidopsis thaliana. 2000 · Molecular and biological interactions between two HIV-1 strains from a coinfected patient reveal the first evidence in favor of viral synergism. 2003 · Development of...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0135cidm_signature_journeys.htmlCIDMKJ-0018 · Pathogen × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0136cidm_signature_journeys.html14 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0137cidm_signature_journeys.html1998 · Evaluation of four methods for rapid identification of Staphylococcus aureus from blood cultures. 2008 · Failure of the BD GeneOhm StaphS/R assay for identification of Australian methicillin-resistant Staphylococcus aureus strains: duplex assays as the "gold standard" in settings of unknown SCCmec epidemiology. 2010 · Unexpected diversity of staphylococcal cassette chromosome mec type IV in methicillin-resi...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0138cidm_signature_journeys.htmlCIDMKJ-0022 · Theme × TechnologyQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0139cidm_signature_journeys.html13 publicationsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0140cidm_signature_journeys.html2002 · Compliance with a protocol for intrapartum antibiotic prophylaxis against neonatal group B streptococcal sepsis in women with clinical risk factors. 2013 · Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. 2015 · Knowing when to stop antibiotic therapy. 2015 · Knowing when to stop antibiotic therapy.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0141cidm_signature_journeys.htmlJourneys provide candidate trunks; Reference Passports can test whether the trunk deserves capability status.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0142cidm_capability_review.htmlCIDM Capability Review · iSydney body{margin:0;background:#eeeae2;color:#172825;font-family:Inter,system-ui;line-height:1.5}.wrap{max-width:1260px;margin:auto;padding:24px}.hero,.card,.sj{background:#fffdf8;border:1px solid #d7d0c4;border-radius:18px;padding:18px}.hero{padding:32px;background:linear-gradient(135deg,#e6f2ed,#fff0df)}h1{font-size:42px;line-height:1.05;margin:7px 0}.k{font-size:11px;text-transform:up...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0143cidm_capability_review.htmliSydney Digital CIDM Explorer Navigator All Journeys Signature Journeys Capability Review 460 GatewayQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0144cidm_capability_review.htmlDigital CIDM has detected 13 recurring technology signals. This page keeps them in a controlled review queue rather than silently declaring them institutional capabilities.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0145cidm_capability_review.htmlCapability rule: frequency is evidence of recurrence, not proof of capability. Promotion requires reviewed publications, evidence links, provenance, and a bounded capability definition.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0146cidm_capability_review.htmlColleague Beta boundary: publication counts and source-derived classifications are working research data. “Observed”, “candidate”, “reviewed”, and “validated” are intentionally different states. A corpus pattern is not automatically an institutional capability or scientific conclusion.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0147cidm_capability_review.htmlCIDMCAPREV-001QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0148cidm_capability_review.html451 publication classifications · 19 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0149cidm_capability_review.htmlcandidate onlySTATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0150cidm_capability_review.htmlCIDMCAPREV-002QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0151cidm_capability_review.html146 publication classifications · 11 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0152cidm_capability_review.htmlCIDMCAPREV-003QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0153cidm_capability_review.html120 publication classifications · 11 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0154cidm_capability_review.htmlCIDMCAPREV-004QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0155cidm_capability_review.html86 publication classifications · 8 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0156cidm_capability_review.htmlCIDMCAPREV-005QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0157cidm_capability_review.html72 publication classifications · 12 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0158cidm_capability_review.htmlCIDMCAPREV-006QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0159cidm_capability_review.html65 publication classifications · 8 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0160cidm_capability_review.htmlCIDMCAPREV-007QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0161cidm_capability_review.html46 publication classifications · 11 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0162cidm_capability_review.htmlCIDMCAPREV-008QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0163cidm_capability_review.html43 publication classifications · 6 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0164cidm_capability_review.htmlCIDMCAPREV-009QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0165cidm_capability_review.html26 publication classifications · 6 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0166cidm_capability_review.htmlCIDMCAPREV-010QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0167cidm_capability_review.html17 publication classifications · 7 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0168cidm_capability_review.htmlCIDMCAPREV-011QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0169cidm_capability_review.html16 publication classifications · 6 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0170cidm_capability_review.htmlCIDMCAPREV-012QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0171cidm_capability_review.html10 publication classifications · 4 pathogen groupsQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0172cidm_capability_review.htmlCIDMCAPREV-013QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0173cidm_capability_review.htmlCandidate signal → Evidence Passport → Human/AI review → Capability Passport.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0174evidence_chain_observatory.htmlbody{margin:0;font-family:system-ui;background:#ebe7df;color:#172825;line-height:1.55}main{max-width:1150px;margin:auto;padding:20px}section{background:#fffdf8;border:1px solid #d7d0c4;border-radius:20px;padding:23px;margin:12px 0}.hero{background:linear-gradient(135deg,#dff1ea,#fff0df,#eee7f4)}h1{font-size:43px}.k{font-size:11px;letter-spacing:.13em;text-transform:uppercase;font-weight:850;color:#27665c}.flow{bac...QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0175evidence_chain_observatory.htmlFor the first time, flagship institutional statements are represented as inspectable Claim Passports with candidate publication evidence, explicit boundaries, review gates and routes back to figures, tables, journeys and Reference Passports.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0176evidence_chain_observatory.htmlReality → Publication → Candidate Evidence Road → Claim Passport → Review → Figure/Table/Journey → New Question → Reality ReturnSTATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0177evidence_chain_observatory.htmlEC-001 · CANDIDATE_EVIDENCE_CHAINQUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0178evidence_chain_observatory.htmlClaim Passport ICIDM-CLAIM-001 Across the publication corpus, molecular diagnostics appears as a recurrent observational capability rather than a single episode.QUANTITATIVEPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0179evidence_chain_observatory.htmlEvidence boundary Recurrence in a publication corpus supports persistence of a research/diagnostic signal, but institutional capability promotion still requires reviewed historical and operational evidence.STATE_OR_BOUNDARYPENDING_CLAIM_REVIEW
ICIDM-CLAIM-0180evidence_chain_observatory.htmlFigure 5 · Technology populations Figure 9 · Technology by era Table 5 · Leading technologies/methods Figure 13 · Capability TopologyQUANTITATIVEPENDING_CLAIM_REVIEW
Scientific Integrity Legend → · Colleague Beta →
HIGH-IMPACT CLAIMS · REVIEW PASS 1

Release-critical statements now have evidence bindings

The first 30 high-impact claims have been separated from the larger review queue and assigned explicit evidence/boundary/release states.

Open High-Impact Claim Review →